Herbert Y Meltzer

  • 70164 Citations
1961 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
1976

Biochemical studies in schizophrenia

Meltzer, H. Y., Jan 1 1976, In : Schizophrenia bulletin. 2, 1, p. 10-18 9 p.

Research output: Contribution to journalReview article

9 Scopus citations

Neuromuscular dysfunction in schizophrenia

Meltzer, H. Y., Jan 1 1976, In : Schizophrenia bulletin. 2, 1, p. 106-135 30 p.

Research output: Contribution to journalReview article

53 Scopus citations

The dopamine hypothesis of schizophrenia: a review

Meltzer, H. Y. & Stahl, S. M., Jan 1 1976, In : Schizophrenia bulletin. 2, 1, p. 19-76 58 p.

Research output: Contribution to journalReview article

606 Scopus citations
1980

Relevance of dopamine autoreceptors for psychiatry: Preclinical and clinical studies

Meltzer, H. Y., Jan 1 1980, In : Schizophrenia bulletin. 6, 3, p. 456-475 20 p.

Research output: Contribution to journalReview article

71 Scopus citations
1982

Effect of benzamide drugs on prolactin secretion: relation to the dopamine receptor.

Meltzer, H. Y., So, R. & Fang, V. S., Dec 1 1982, In : Advances in biochemical psychopharmacology. 35, p. 61-82 22 p.

Research output: Contribution to journalReview article

4 Scopus citations

Effect of serotonin precursors and serotonin agonists on plasma hormone levels.

Meltzer, H. Y., Wiita, B., Tricou, B. J., Simonovic, M., Fang, V. & Manov, G., Jan 1 1982, In : Advances in biochemical psychopharmacology. 34, p. 117-139 23 p.

Research output: Contribution to journalReview article

65 Scopus citations
1983

The nosology of schizoaffective psychosis.

Brockington, I. F. & Meltzer, H. Y., Dec 1 1983, In : Psychiatric Developments. 1, 4, p. 317-338 22 p.

Research output: Contribution to journalReview article

30 Scopus citations
1984

Dopaminergic and serotonergic control of neuroendocrine function.

Gudelsky, G. A., Simonovic, M. & Meltzer, H. Y., Jan 1 1984, In : Monographs in neural sciences. 10, p. 85-102 18 p.

Research output: Contribution to journalReview article

9 Scopus citations
1985

Long-term effects of neuroleptic drugs on the neuroendocrine system.

Meltzer, H. Y., Jan 1 1985, In : Advances in biochemical psychopharmacology. 40, p. 59-68 10 p.

Research output: Contribution to journalReview article

35 Scopus citations
1987

Dexamethasone bioavailability: Implications for DST research

Lowy, M. T. & Meltzer, H. Y., Jan 1 1987, In : Biological psychiatry. 22, 3, p. 373-385 13 p.

Research output: Contribution to journalReview article

67 Scopus citations
1988

Platelet MAO activity in hallucinating and paranoid schizophrenics: A review and meta-analysis

Zureick, J. L. & Meltzer, H. Y., May 1988, In : Biological psychiatry. 24, 1, p. 63-78 16 p.

Research output: Contribution to journalReview article

29 Scopus citations
1989

Negative symptoms in schizophrenia: a target for new drug development.

Meltzer, H. Y. & Zureick, J., Dec 1 1989, In : Psychopharmacology series. 7, p. 68-77 10 p.

Research output: Contribution to journalReview article

20 Scopus citations
1991

The neurobiology of schizophrenia

Meltzer, H. Y., Jan 1 1991, In : Current Opinion in Psychiatry. 4, 1, p. 90-95 6 p.

Research output: Contribution to journalReview article

6 Scopus citations
1992

Dimensions of outcome with clozapine

Meltzer, H. Y., Jan 1 1992, In : British Journal of Psychiatry. 160, MAY. SUPPL. 17, p. 46-53 8 p.

Research output: Contribution to journalReview article

226 Scopus citations

The importance of serotonin-dopamine interactions in the action of clozapine

Meltzer, H. Y., Jan 1 1992, In : British Journal of Psychiatry. 160, MAY. SUPPL. 17, p. 22-29 8 p.

Research output: Contribution to journalReview article

133 Scopus citations
1993

New drugs for the treatment of schizophrenia

Meltzer, H. Y., Jan 1 1993, In : Psychiatric Clinics of North America. 16, 2, p. 365-385 21 p.

Research output: Contribution to journalReview article

74 Scopus citations

Serotonin receptors and antipsychotic drug action.

Meltzer, H. Y., 1993, In : Psychopharmacology series. 10, p. 70-81 12 p.

Research output: Contribution to journalReview article

10 Scopus citations
1995

Neuroleptic withdrawal in schizophrenic patients: A review of the literature

Gilbert, P. L., Harris, M. J., McAdams, L. A., Jeste, D. V., Baldessarini, R. J., Viguera, A. C., Carpenter, W. T., Tamminga, C. A., Greden, J. F., Tandon, R., Meltzer, H. Y., Nuechterlein, K. H., Gitlin, M. J., Subotnik, K. L. & Wyatt, R. J., Jan 1 1995, In : Archives of general psychiatry. 52, 3, p. 173-212 40 p.

Research output: Contribution to journalReview article

397 Scopus citations

Role of serotonin in the action of atypical antipsychotic drugs.

Meltzer, H. Y., 1995, In : Clinical neuroscience (New York, N.Y.). 3, 2, p. 64-75 12 p.

Research output: Contribution to journalReview article

164 Scopus citations
1996

Pre-clinical pharmacology of atypical antipsychotic drugs: A selective review

Meltzer, H. Y., Jan 1 1996, In : British Journal of Psychiatry. 168, MAY SUPPL. 29, p. 23-31 9 p.

Research output: Contribution to journalReview article

68 Scopus citations
1997

Practice guideline for the treatment of patients with schizophrenia

Herz, M. I., Liberman, R. P., McGlashan, T. H., Lieberman, J. A., Wyatt, R. J., Marder, S. R., Wang, P., Allgulander, C., Baldessarini, R. J., Balon, R., Bellack, A. S., Berlin, J., Blackington, C. H., Buckley, P., Carlson, D. G., Cott, J., Cournos, F., Desai, P., Dickstein, L., Fenton, W. S. & 78 others, Fisher, W. A., Flaherty, L. T., Freedman, R., Galanter, M., Galton, E., Ganguli, R., Garrettson, L. K., Goldfinger, S., Goldman, L. S., Goldstein, M. Z., Gordy, T. R., Gray, S. H., Green, M. R., Greenberg, W. M., Gunderson, J. G., Hall, L. L., Haller, E., Hanin, E., Hawkins, L., Hester, T. W., Horn, T., Hsiao, J. K., Juthani, N. V., Kane, J. M., Kayser, A., Kibel, H. D., Kimmich, R. A., Koegler, R. R., Krajeski, J., Kuehnel, T., Lamberti, J. S., Lehman, A., Leunello, J., Martin, R. L., McCarley, R., McGee, M., Meltzer, H. Y., Mesulam, M., Metzner, J. L., Mosher, L. R., Motto, J. A., Mueser, K. T., Munoz, R. A., Nasrallah, H. A., Newcomer, J. W., Opler, L. A., Peterson, G. N., Rapaport, M., Riba, M., Rickert, V. I., Rifkin, A., Rivenbark, J. S., Robertson, S., Ruiz, P., Ryan, W. G., Sanderson, M. O., Schiffer, R. B., Schyve, P. M., Sebring, R. H., Shen, W. W., Shore, D., Simpson, G. M., Soufi, H. E., Stein, L. I., Stotland, N., Strauss, J., Sundberg, D., Svendsen, D., Tohen, M., Tsuang, M., Wagnitz, J. G., Weiner, R., Weitzel, W. D., Wilkerson, L. J., Wingerson, D., Zarate, J., Zito, J. & Zonana, H. V., Jan 1 1997, In : American Journal of Psychiatry. 154, 4 SUPPL., p. 1-63 63 p.

Research output: Contribution to journalReview article

692 Scopus citations

Treatment-resistant schizophrenia - The role of clozapine

Meltzer, H. Y., Jan 1 1997, In : Current Medical Research and Opinion. 14, 1, p. 1-20 20 p.

Research output: Contribution to journalReview article

269 Scopus citations
1998

Adverse effects of the atypical antipsychotics

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 17-22 6 p.

Research output: Contribution to journalReview article

103 Scopus citations

Assessing the effects of atypical antipsychotics on negative symptoms

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 28-34 7 p.

Research output: Contribution to journalReview article

41 Scopus citations

Assessment of EPS and tardive dyskinesia in clinical trials

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 23-27 5 p.

Research output: Contribution to journalReview article

36 Scopus citations

Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 41-45 5 p.

Research output: Contribution to journalReview article

51 Scopus citations

Clinical development of atypical antipsychotics: Research design and evaluation

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 10-16 7 p.

Research output: Contribution to journalReview article

20 Scopus citations

Evaluating the effects of antipsychotics on cognition in schizophrenia

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 35-40 6 p.

Research output: Contribution to journalReview article

33 Scopus citations

Measuring outcome in schizophrenia: Differences among the atypical antipsychotics

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 3-9 7 p.

Research output: Contribution to journalReview article

37 Scopus citations

Suicide in schizophrenia: Risk factors and clozapine treatment

Meltzer, H. Y., Jan 1 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 3, p. 15-20 6 p.

Research output: Contribution to journalReview article

109 Scopus citations

Treatment of special populations with the atypical antipsychotics

Meltzer, H. Y., Oct 5 1998, In : Journal of Clinical Psychiatry. 59, SUPPL. 12, p. 46-52 7 p.

Research output: Contribution to journalReview article

28 Scopus citations
1999

Pharmacoeconomic factors related to the treatment of schizophrenia

Meltzer, H., Awad, A. G., Manning W.G., J., Shon, S. P., Diamond, R., Mahmoud, R. & Weisburd, D. E., Mar 10 1999, In : Journal of Clinical Psychiatry. 60, SUPPL. 3, p. 59-60 2 p.

Research output: Contribution to journalReview article

Suicide and schizophrenia: Clozapine and the InterSePT study

Meltzer, H. Y., Jun 30 1999, In : Journal of Clinical Psychiatry. 60, SUPPL. 12, p. 47-50 4 p.

Research output: Contribution to journalReview article

78 Scopus citations

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

Meltzer, H. Y. & McGurk, S. R., Jan 1 1999, In : Schizophrenia bulletin. 25, 2, p. 233-255 23 p.

Research output: Contribution to journalReview article

897 Scopus citations

Variability in response to clozapine: Potential role of cytochrome P450 1A2 and the dopamine D4 receptor gene

Ozdemir, V., Masellis, M., Basile, V. S., Kalow, W., Meltzer, H. Y., Lieberman, J. A. & Kennedy, J. L., Jun 30 1999, In : CNS spectrums. 4, 6, p. 30-56 27 p.

Research output: Contribution to journalReview article

20 Scopus citations
2000

Adverse events related to olanzapine

Conley, R. R. & Meltzer, H. Y., May 22 2000, In : Journal of Clinical Psychiatry. 61, SUPPL. 8, p. 26-30 5 p.

Research output: Contribution to journalReview article

70 Scopus citations

Pharmacogenetics of antipsychotic treatment: Lessons learned from clozapine

Masellis, M., Basile, V. S., Özdemir, V., Meltzer, H. Y., Macciardi, F. M. & Kennedy, J. L., Feb 1 2000, In : Biological psychiatry. 47, 3, p. 252-266 15 p.

Research output: Contribution to journalReview article

78 Scopus citations

Psychological and behavioural effects of interferons

Bonaccorso, S., Meltzer, H. & Maes, M., Nov 25 2000, In : Current opinion in psychiatry. 13, 6, p. 673-677 5 p.

Research output: Contribution to journalReview article

37 Scopus citations

Reducing suicide risk in schizophrenia: Focus on the role of clozapine

Meltzer, H. Y., Anand, R. & Alphs, L., Jan 1 2000, In : CNS Drugs. 14, 5, p. 355-365 11 p.

Research output: Contribution to journalReview article

26 Scopus citations
2001

Genetic dissection of atypical antipsychotic-induced weight gain: Novel preliminary data on the pharmacogenetic puzzle

Basile, V. S., Masellis, M., McIntyre, R. S., Meltzer, H. Y., Lieberman, J. A. & Kennedy, J. L., Oct 22 2001, In : Journal of Clinical Psychiatry. 62, SUPPL. 23, p. 45-66 22 p.

Research output: Contribution to journalReview article

205 Scopus citations

Putting metabolic side effects into perspective: Risks versus benefits of atypical antipsychotics

Meltzer, H. Y., Dec 1 2001, In : Journal of Clinical Psychiatry. 62, SUPPL. 27, p. 35-39 5 p.

Research output: Contribution to journalReview article

44 Scopus citations
2002

Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.

Meltzer, H. Y., Davidson, M., Glassman, A. H. & Vieweg, W. V. R., Jan 1 2002, In : The Journal of clinical psychiatry. 63 Suppl 9, p. 25-29 5 p.

Research output: Contribution to journalReview article

45 Scopus citations

Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options.

Meltzer, H. Y., Jan 1 2002, In : Current Psychiatry Reports. 4, 4, p. 279-283 5 p.

Research output: Contribution to journalReview article

90 Scopus citations
2003

Antipsychotic drugs in bipolar disorder

Ertugrul, A. & Meltzer, H. Y., Sep 1 2003, In : International Journal of Neuropsychopharmacology. 6, 3, p. 277-284 8 p.

Research output: Contribution to journalReview article

31 Scopus citations

Neurocognitive assessment in the clinical antipsychotic trials of intervention effectiveness (CATIE) project schizophrenia trial: Development, methodology, and rationale

Keefe, R. S. E., Mohs, R. C., Bilder, R. M., Harvey, P. D., Green, M. F., Meltzer, H. Y., Gold, J. M. & Sano, M., Jan 1 2003, In : Schizophrenia bulletin. 29, 1, p. 45-55 11 p.

Research output: Contribution to journalReview article

91 Scopus citations

Psychosis of Parkinson's disease: Serotonin 2A receptor inverse agonists as potential therapeutics

Weiner, D. M., Vanover, K. E., Brann, M. R., Meltzer, H. Y. & Davis, R. E., Jul 1 2003, In : Current Opinion in Investigational Drugs. 4, 7, p. 815-819 5 p.

Research output: Contribution to journalReview article

17 Scopus citations
2004

The International Suicide Prevention Trial (InterSePT): Rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients

Alphs, L., Anand, R., Islam, M. Z., Meltzer, H. Y., Kane, J. M., Krishnan, R., Green, A. I., Potkin, S., Chouinard, G., Lindenmayer, J. P. & Kerwin, R., Jan 1 2004, In : Schizophrenia bulletin. 30, 3, p. 577-586 10 p.

Research output: Contribution to journalReview article

31 Scopus citations

What's atypical about atypical antipsychotic drugs?

Meltzer, H. Y., Feb 2004, In : Current Opinion in Pharmacology. 4, 1, p. 53-57 5 p.

Research output: Contribution to journalReview article

126 Scopus citations
2005

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia

Woodward, N. D., Purdon, S. E., Meltzer, H. Y. & Zald, D. H., Sep 1 2005, In : International Journal of Neuropsychopharmacology. 8, 3, p. 457-472 16 p.

Research output: Contribution to journalReview article

451 Scopus citations